Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure (Q44617780)

4 December 2017

Pharmacokinetics and hemodynamic effects of the phosphodiesterase III inhibitor saterinone in patients with chronic heart failure (English)

1 reference

4 December 2017

1 reference

chronic heart failure

1 reference

Cardiology and cardiovascular medicine

inferred from title

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00030-5

21 March 2024

author name string

A. G. Kieback

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

H. Iven

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

K. Stolzenburg

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

E. Eichner

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

W. Ruckdeschel

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

G. Baumann

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A14559131

21 March 2024

language of work or name

English

0 references

publication date

1 October 2003

1 reference

full work available at URL

4 December 2017

https://api.elsevier.com/content/article/PII:S0167527303000305?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00030-5

https://api.elsevier.com/content/article/PII:S0167527303000305?httpAccept=text/plain

21 March 2024

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00030-5

International Journal of Cardiology

21 March 2024

published in

1 reference

4 December 2017

91

1 reference

4 December 2017

2-3

1 reference

4 December 2017

201-208

1 reference

Mechanisms of cardiac contraction: What roles for preload, afterload and inotropic state in heart failure?

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Afterload as a primary determinat of ventricular performance

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Impaired beta-adrenergic stimulation in the uninvolved ventricle post-acute myocardial infarction: Reversible defect due to excessive circulating catecholamine-induced decline in number and affinity of beta-receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Myocardial beta-adrenergic receptor downregulation in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Saterinone, dobutamine, and sodium nitroprusside: comparison of cardiovascular profiles in patients with congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Comparison of acute haemodynamic effects of dopexamine hydrochloride, dobutamine and sodium nitroprusside in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Determination of saterinone in plasma by high-performance liquid chromatography

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Analysis of [14C]-saterinone and its metabolites in dog plasma, urine and bile by high-performance liquid chromatography with radioactivity and fluorescence detection and by mass spectrometry

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Hemodynamic and autonomic effects of intravenous saterinone in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

A comparison of oral milrinone, digoxin, and their combination in the treatment of patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Usefulness of dopexamine hydrochloride versus dobutamine in chronic congestive heart failure and effects on hemodynamics and urine output

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

A comparison of enalapril with hydralazine-isosorbide dinitrate in the treatment of chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Effect of oral milrinone on mortality in severe chronic heart failure. The PROMISE Study Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Randomised study of effect of ibopamine on survival in patients with advanced severe heart failure. Second Prospective Randomised Study of Ibopamine on Mortality and Efficacy (PRIME II) Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Contrasting Effects of Cyclic AMP Increase Caused by β-Adrenergic Stimulation or by Adenylate Cyclase Activation on Ventricular Fibrillation Threshold of Isolated Rat Heart

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Cardioprotective effect afforded by transient exposure to phosphodiesterase III inhibitors: the role of protein kinase A and p38 mitogen-activated protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0167-5273%2803%2900030-5

7 January 2021

Cardiovascular Effects of Forskolin (HL 362) in Patients with Idiopathic Congestive Cardiomyopathy—A Comparative Study with Dobutamine and Sodium Nitroprusside

9

1 reference

https://api.crossref.org/works/10.1016/S0167-5273(03)00030-5

21 March 2024

Identifiers

1 reference

4 December 2017

1 reference